CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: March 26, 2007
Result type: Reports
Project Number: SR0095-000
Product Line: Reimbursement Review

Generic Name: Ramipril/hydrochlorothiazide

Brand Name: Altace HCT

Manufacturer: Sanofi-Aventis Canada Inc.

Therapeutic Area: Hypertension

Indications: Hypertension

Submission Type: Resubmission

Project Status: Complete

Date Recommendation Issued: June 14, 2007

Recommendation Type: List